Northwestern University

NAB2::STAT6 fusions and genome-wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors (2024) Eschbacher KL, Tran QT, Moskalev E, Jenkins S, Fritchie K, Stöhr R, Caron A, et al. Journal article Characterization of hyperpolarization-activated cyclic nucleotide-gated channels in oligodendrocytes. (2024) Lyman KA, Han Y, Robinson AP, Weinberg SE, Fisher DW, Heuermann RJ, Lyman RE, et al. Journal article Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop (2024) Yuen KC, Ghalib L, Buchfelder M, Hughes J, Langlois F, Molitch ME Journal article, Review article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article Do Existing MRI Definitions of Knee Osteoarthritis Identify Knees That Will Develop Clinically Significant Disease Over Up To 11 Years of Follow-Up? (2024) Chang AH, Roemer F, Guermazi A, Almagor O, Lee J, Chmiel JS, Muhammad LN, et al. Journal article High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq (2023) Benotmane JK, Kueckelhaus J, Will P, Zhang J, Ravi VM, Joseph K, Sankowski R, et al. Journal article Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models (2023) Drobny A, Boros FA, Balta D, Prieto Huarcaya S, Caylioglu D, Qazi N, Vandrey J, et al. Journal article Vision on metal additive manufacturing: Developments, challenges and future trends (2023) Bernard A, Kruth JP, Cao J, Lanza G, Bruschi S, Merklein M, Vaneker T, et al. Journal article Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition (2023) Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, Easton A, et al. Journal article, Review article Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023) Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al. Journal article